Newsroom

Print
 
 
12/10/2020 Bio-Rad Provides Outlook Through 2023
More
10/29/2020 Bio-Rad Reports Third-Quarter 2020 Financial Results
More
10/19/2020 Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020
More
08/04/2020 The United States Court of Appeals for the Federal Circuit Affirms that 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of Damages
More
07/30/2020 Bio-Rad Reports Second-Quarter 2020 Financial Results
More
07/15/2020 Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020
More
05/06/2020 Bio-Rad Reports First-Quarter 2020 Financial Results
More
05/04/2020 Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit
More
04/30/2020 Bio-Rad’s SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA
More
04/22/2020 Bio-Rad to Report First-Quarter 2020 Financial Results Wednesday, May 6, 2020
More
04/21/2020 Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity
More
04/09/2020 Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider
More
04/07/2020 Bio-Rad Announces the Launch of a Serology Assay to Detect Coronavirus (COVID-19) Antibodies
More
03/19/2020 New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 with Greater Sensitivity and Precision than Other Existing Molecular Tests
More
03/18/2020 Bio-Rad Partners with Testing Labs Worldwide to Support COVID-19 Testing
More
03/12/2020 Bio-Rad Announces that Through its Exact Diagnostics Product Line, the Company has Launched a SARS CoV-2 Standard for Coronavirus (COVID-19) Testing
More
02/13/2020 Bio-Rad Reports Fourth-Quarter and Full-Year 2019 Financial Results
More
02/03/2020 Bio-Rad to Report Fourth-Quarter and Full-Year 2019 Financial Results Thursday, February 13, 2020
More
01/06/2020 Bio-Rad Appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
More
01/02/2020 Bio-Rad to Participate at the 38th Annual J.P. Morgan Healthcare Conference on January 13
More
Get Help

Media Contacts

Tina Cuccia
Corporate Communications Manager
Phone: +1-510-741-6063
tina_cuccia@bio-rad.com

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.